Exagen Inc. (NASDAQ: XGN) Stock Information | RedChip

Exagen Inc. (NASDAQ: XGN)


$5.0000
+0.0500 ( -1.96% ) 62.2K

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Market Data


Open


$5.0000

Previous close


$4.9500

Volume


62.2K

Market cap


$83.16M

Day range


$4.7480 - $5.2200

52 week range


$1.3003 - $6.2200

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 27, 2024
4 Insider transactions 1 Nov 19, 2024
4 Insider transactions 1 Nov 18, 2024
8-k 8K-related 15 Nov 12, 2024
10-q Quarterly Reports 60 Nov 12, 2024
4 Insider transactions 1 Sep 04, 2024
3 Insider transactions 1 Sep 04, 2024
10-q Quarterly Reports 60 Aug 05, 2024
8-k 8K-related 15 Aug 05, 2024
8-k 8K-related 17 Aug 02, 2024

Latest News